The Lancet Diabetes & Endocrinology in conversation with
Editors at The Lancet Diabetes & Endocrinology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from thyroid cancer to childhood obesity, the mechanisms of ageing to erectile dysfunction, and more.
The Lancet Diabetes & Endocrinology in conversation with
Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.
Read the full article:
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv